Toggle sidebar
定价
登录
Cancer testing
搜索文档
Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink
Barrons
·
2026-07-20 22:44
公司信息 - Tempus AI是一家医疗科技公司,并且是投资者凯茜·伍德青睐的对象 [1] - Personalis公司从事癌症检测业务 [1]
Personalis(US:PSNL)
Healthcare technology
Healthcare Technology
Cancer testing
Healthcare technology
Healthcare Technology
Cancer testing